Active DNA demethylation in post-mitotic neurons: a reason for optimism

David P Gavin1, Kayla A Chase2, Rajiv P Sharma1

  • 1The Psychiatric Institute, Department of Psychiatry, University of Illinois at Chicago, 1601 W. Taylor St., Chicago, IL 60612, USA; Jesse Brown Veterans Affairs Medical Center, 820 South Damen Avenue (M/C 151), Chicago, IL 60612, USA.

Neuropharmacology
|August 21, 2013
PubMed

Insights

Base excision repair (BER) proteins drive active DNA demethylation, reprogramming dysfunctional neurons. This epigenetic pathway offers new hope for treating chronic mental illnesses like schizophrenia by targeting neuronal identity.

Area of Science:

  • Epigenetics
  • Neuroscience
  • Molecular Biology

Background:

  • DNA methylation is a key epigenetic regulator of neuronal identity.
  • Chronic mental illnesses may involve dysfunctional neuronal identities maintained by DNA methylation.
  • Active DNA demethylation in post-mitotic neurons was previously considered unlikely.

Purpose of the Study:

  • To review the role of base excision repair (BER) proteins in active DNA demethylation.
  • To explain the mechanism of BER-mediated DNA demethylation in neurons.
  • To discuss the therapeutic potential of targeting epigenetic processes in psychiatry.

Main Methods:

  • Literature review of studies on BER and DNA demethylation.
  • Analysis of evidence for BER pathway operation in post-mitotic neurons.
  • Discussion of implications for neuronal identity and mental illness.

Main Results:

  • BER proteins are involved in active DNA demethylation, removing epigenetic marks.
  • The BER pathway is active in post-mitotic neurons, challenging previous assumptions.
  • This pathway can reprogram dysfunctional neuronal identities.

Conclusions:

  • Active DNA demethylation via BER in neurons provides a mechanism for reversing pathological changes.
  • Targeting epigenetic processes offers a promising therapeutic strategy for mental illnesses.
  • This approach may lead to significant advancements over traditional psychopharmacology.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...